Invesco’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-584
| Closed | -$15.7K | – | 3968 |
|
|
2023
Q1 | $15.7K | Buy |
584
+102
| +21% | +$2.74K | ﹤0.01% | 3804 |
|
|
2022
Q4 | $17K | Sell |
482
-54
| -10% | -$1.91K | ﹤0.01% | 3961 |
|
|
2022
Q3 | $121K | Buy |
536
+67
| +14% | +$15.1K | ﹤0.01% | 3776 |
|
|
2022
Q2 | $89K | Buy |
+469
| New | +$89K | ﹤0.01% | 3877 |
|
|
2021
Q4 | – | Sell |
-382
| Closed | -$76K | – | 4081 |
|
|
2021
Q3 | $76K | Buy |
382
+45
| +13% | +$8.95K | ﹤0.01% | 3939 |
|
|
2021
Q2 | $86K | Buy |
+337
| New | +$86K | ﹤0.01% | 3884 |
|